Milk Thistle (Silymarin): Check the Silymarin Number on the Label
Milk thistle's active is silymarin — and many labels do not state how much is in the bottle. Silymarin is a flavonolignan complex (main component: silibinin) that the research doses in milligrams of silymarin, not seed weight. The trap: a quality extract states an extract mg and a silymarin % (~70–80%), so actual active = extract mg × %; some products headline "1,000 mg," "3,000 mg," "4:1," or "full-spectrum" with no %. Testing reported content varying ~2,800% between products (Fenclová 2019: 35–125% of label). Of 12 products we track, only 5 disclose a silymarin %. The research is modest and mixed, with no confirmed mortality benefit in cirrhosis.
Educational overview — not medical advice. The most commonly reported side effect is mild GI upset; the cautions that matter are a ragweed-family allergy and possible additive blood-sugar lowering with antidiabetic drugs — see what the research says.
Ranked by disclosed silymarin, never commissions.
Start here
What milk thistle is (and what the research measures)
Milk thistle (Silybum marianum) is sold for "liver support," and the compound behind the research is silymarin — a family of flavonolignans whose main component is silibinin (silybin). Silymarin is what the trials standardize on, and the pharmacopeial convention (USP / German Commission E) is an extract standardized to about 70–80% silymarin (composition per NIH LiverTox). So the first question isn't dose — it's whether the bottle even tells you its silymarin content, because the big milk-thistle milligram number on the front is not the active.
The disclosure moat, briefly
A quality product prints both an extract mg and a silymarin %, so you can compute the active with a single multiplication (extract mg × %). Some products headline a big raw number — "1,000 mg" softgels, "3,000 mg" 4:1 extracts, "full-spectrum" seed — with no silymarin %, so the active is unknowable. And it genuinely varies: independent testing (ConsumerLab) found silymarin per serving swinging ~2,800% (2 of 6 at 40–60% of label), and peer-reviewed testing found 35–125% of the declared amount (Fenclová 2019). That's why a true cost-per-active ranking is possible only for the disclosers.
The one-line takeaway Silymarin is the point, and it's computable only when a silymarin % is printed — yet of the 12 products we track, only 5 disclose a percentage. So shop on disclosure first, not on the milligram number. The research is mixed, and nothing here shows milk thistle treats a liver condition.
What the research says (the short version)
The research is modest and mixed. Start with the mortality question: a Cochrane review found no significant all-cause mortality benefit in cirrhosis, and the liver-mortality signal was not significant in high-quality trials (Rambaldi 2007). A pooled analysis of 26 fatty-liver trials looked at ALT/AST (Li 2024), lab markers of debated clinical relevance. Data on fasting glucose in type 2 diabetes come from low-quality trials (Voroneanu 2016).
On this page
What Milk Thistle Has Been Studied For
See our best milk thistle ranked by disclosed silymarin and cost →
Liver enzyme numbers: what one meta-analysis reported
A 2024 systematic review and meta-analysis of 26 randomized controlled trials in 2,375 people with nonalcoholic fatty liver disease reported lower ALT (standardized mean difference −12.39) and AST (−10.97) with silymarin, along with total cholesterol, LDL, and a fatty-liver index (Li 2024, PMID: 38579127). Insulin resistance (HOMA-IR) trended down but didn't reach statistical significance. The review's own authors state that these are enzyme and imaging markers, not confirmed health outcomes, and that the effect needs confirming in further research. For the full topic-by-topic table, see our milk thistle evidence page.
Why results are inconsistent: absorption, and phosphatidylcholine complexes
A likely reason milk thistle results are inconsistent is that plain silymarin is poorly and unevenly absorbed orally. A human pharmacokinetic study comparing a silybin-phosphatidylcholine complex (IdB 1016, marketed as Siliphos or Realsil) against an equivalent dose of plain silymarin found the complex produced substantially higher blood silybin levels at every time point measured, and confirmed that complexation with phosphatidylcholine improves how much crosses the gut lining into circulation (Barzaghi 1990, PMID: 2088770). That's the actual scientific rationale behind "phytosome" or phosphatidylcholine-complex milk thistle products commanding a premium — and a reasonable factor in why some trials of plain silymarin underperform.
Layer inconsistent manufacturing on top of inconsistent absorption. Independent testing of 26 commercial milk thistle supplements from US and Czech markets found large differences in actual silymarin content, often at odds with what the label claimed, plus contamination with mycotoxins and pesticides across every product tested (Fenclova 2019, PMID: 31366891). Between a poorly absorbed active ingredient and a product category where the dose on the label isn't reliable, a trial finding a small change and a bottle failing to reproduce it are not really in tension — see our label-trap breakdown for how to buy around this.
Standardization, drug interactions, and who should be cautious
A quality product is standardized to ~70–80% silymarin, so the practical buying signal is a printed silymarin percentage you can multiply against the extract weight — see our dosage guide for how to run that math. On drug interactions, the concern is smaller than early lab research suggested: human studies of specific drugs found no significant change in their blood levels (see our side effects page). That's a small set of drugs, not a blanket clearance, so it's still worth telling a pharmacist you're taking it. Two cautions do hold up: milk thistle is in the ragweed family (Asteraceae), so people allergic to ragweed, daisies, or chrysanthemums may react to it (NCCIH; MedlinePlus), and because silymarin may modestly lower fasting glucose in small trials (Voroneanu 2016, PMID: 27340676, rated low-quality evidence), anyone on antidiabetic medication should monitor and check with a clinician before stacking the two.
Milk thistle studies at a glance
| Topic | What the trials found | Verdict |
|---|---|---|
| Liver enzyme numbers (fatty liver studies) | ALT/AST reported lower across 26 RCTs / 2,375 patients (Li 2024) | Small change in lab markers |
What the Research Says About Milk Thistle and Silymarin
What "the active" is, and why the dose is always silymarin
Milk thistle's studied effects trace to silymarin, a complex of flavonolignans whose main component is silibinin (silybin). Trials dose in silymarin milligrams, not seed milligrams — which is why the number that matters is almost never the big figure on the front of the bottle (see the label trap). Every result below only means something if you actually get a real silymarin dose, which many labels do not disclose.
What the trials show — by outcome
| Outcome | Design | Finding | The honest limit |
|---|---|---|---|
| Liver enzymes / NAFLD Li 2024 · Zhong 2017 | Meta-analysis, 26 RCTs / 2,375 (Li) | ALT SMD −12.4, AST SMD −11.0 (Li 2024); concrete ALT −9.2 U/L, AST −6.6 U/L (Zhong 2017) | Statistically real, clinical relevance debated. An enzyme drop isn't a proven change in liver outcomes — the honest read is "a change in lab numbers," not a health outcome. |
Read together: the case is modest and specific — a small change in lab numbers whose clinical meaning is debated. A narrative review of 29 RCTs is consistent, finding enzymes fell in about 65.5% of studies but without a pooled effect size (Calderon Martinez 2023). No trial supports a "detox" or "cleanse" claim.
Safety and interactions
Milk thistle was generally well tolerated in studies at label doses; the main reported side effects are mild gastrointestinal upset (loose stools, nausea). Two cautions are worth respecting:
What to keep in mind
- The dose has to be real — a label that prints the silymarin percentage, not just the total extract weight. See the dosage guide.
- Not a substitute for medical care.
Skip or get medical advice first if you: take antidiabetic drugs (possible additive lowering), have a ragweed-family allergy, or are pregnant or breastfeeding.
Milk Thistle Side Effects: GI Upset and Ragweed Allergy
See our best milk thistle ranked by disclosed silymarin and cost →
The common effect: mild GI upset, and not much else
The side effect you're most likely to notice with milk thistle is gastrointestinal: loose stools, nausea, or bloating. A comprehensive review of the silymarin clinical literature, screening over 500 references down to 36 studies suitable for detailed analysis, found milk thistle generally well tolerated in the studies reviewed, with GI disturbances the most frequently reported adverse effect and allergic skin rash reported only occasionally (Saller 2001, PMID: 11735632). That's consistent with what shows up across the individual trials on our evidence page: adverse events in the silymarin arms were generally comparable to placebo, and discontinuations for side effects were uncommon. There isn't a well-established dose-response relationship the way there is with some other GI-irritating botanicals — most people either tolerate it without issue or notice mild upset early on.
The allergy question: milk thistle is a ragweed relative
Milk thistle (Silybum marianum) is a member of the Asteraceae family — the same family as ragweed, daisies, chrysanthemums, and marigolds. Cross-reactivity between plants in the same botanical family is a recognized allergy pattern, and it's the reason NCCIH and MedlinePlus both flag ragweed-family allergy as a caution for milk thistle. This isn't purely theoretical: a 2020 case report described a man who developed respiratory symptoms (a reaction pattern consistent with inhalant exposure) after occupational exposure to milk thistle, along with oral allergy symptoms after eating teff, a botanically related grain — both confirmed by skin testing with the native allergens (Wojas 2020, PMID: 32322285).
Ingested capsules and inhaled plant material are different exposure routes, and most people taking a milk thistle supplement aren't breathing in the ground plant the way an occupational or environmental exposure might involve. But the underlying allergen cross-reactivity is a real, family-level phenomenon, not a manufacturer's boilerplate warning. If you have a diagnosed ragweed, daisy, or related Asteraceae allergy, treat that as a real reason to check with a doctor before starting milk thistle, not a box to skip past.
Drug interactions: what the lab work suggested, and what human studies found
This is the safety question where precision matters most, because the two bodies of evidence point in different directions. In a test-tube study using human liver microsomes — isolated liver enzyme preparations, not a person — silybin and related silymarin compounds measurably inhibited several cytochrome P450 enzymes (Zuber 2002, PMID: 12410543). Findings like that are exactly why milk thistle carries a drug-interaction caution on paper, and if you stopped reading there, you'd reasonably worry it behaves like berberine or St. John's wort.
But when the same question was tested in actual people taking milk thistle, the picture looked different. Researchers gave healthy volunteers a standardized milk thistle product for 14 days, then measured its effect on midazolam, a drug used specifically as a marker of CYP3A4 enzyme activity, alongside rifampin and clarithromycin as positive controls known to strongly induce or inhibit that enzyme. Rifampin increased midazolam clearance more than 20-fold and clarithromycin decreased it by 88% — both drugs behaved exactly as expected — while milk thistle produced no significant change in midazolam's pharmacokinetics, leading the authors to conclude it has no clinically relevant effect on CYP3A activity in vivo (Gurley 2006, PMID: 16432272). A separate trial from the same research group found milk thistle supplementation didn't meaningfully change digoxin levels, a standard marker for P-glycoprotein, another transporter milk thistle was flagged for inhibiting in the lab (Gurley 2006, PMID: 16221754).
Two separate human trials, two different drugs, the same result: no clinically meaningful interaction. That's a real, tested pattern, not a hand-wave dismissal of the in-vitro data — but it's a pattern across the specific drugs studied, not proof for every CYP3A4 or P-glycoprotein substrate. If you take a medication with a narrow dosing range, especially one metabolized the same way, tell your doctor or pharmacist you're taking milk thistle rather than assuming the human data automatically covers your specific drug.
Two more cautions: blood sugar and a theoretical estrogen effect
Silymarin may modestly lower fasting glucose. A meta-analysis of five small randomized trials reported changes in fasting glucose and HbA1c, though the authors rated the underlying evidence low quality (Voroneanu 2016, PMID: 27340676). If that effect is real, it would add to the glucose-lowering effect of insulin or oral diabetes medication, so anyone on those drugs should monitor blood sugar and loop in a clinician rather than adding milk thistle on their own.
Separately, an animal study found silymarin acts as a selective estrogen receptor beta agonist, producing estrogen-like effects in bone in ovariectomized rats while having no estrogenic (or even mildly anti-estrogenic) effect in the uterus of the same animals (Seidlóvá-Wuttke 2003, PMID: 14568570). That's receptor-binding and rodent data, not a human safety trial, and it doesn't mean milk thistle behaves like a hormone in people. But it's the actual research basis for the standard caution against milk thistle in pregnancy, breastfeeding, and hormone-sensitive health issues — a theoretical concern grounded in a real finding, stated as exactly that.
Milk thistle side effects at a glance
| Issue | What the evidence shows | Who it matters most for |
|---|---|---|
| GI upset (loose stools, nausea, bloating) | Most commonly reported effect across decades of trials; generally well tolerated overall | Anyone — the default tolerability issue, usually mild |
| Ragweed-family (Asteraceae) allergy | Recognized cross-reactivity; a documented case of confirmed allergic reaction | Anyone with a ragweed, daisy, or Asteraceae allergy |
| Drug interactions (CYP3A4 / P-glycoprotein) | In-vitro inhibition seen in liver microsomes, but 2 separate human trials (midazolam, digoxin) found no clinically meaningful effect | Anyone on a narrow-therapeutic-index drug not yet specifically tested |
| Added glucose-lowering effect | Small fasting-glucose changes across small trials rated low quality | Anyone on insulin or oral diabetes medication |
| Theoretical estrogenic activity | Selective estrogen receptor beta agonism shown in an animal (rat) model, not tested in humans | Pregnancy, breastfeeding, hormone-sensitive health issues |
Frequently asked questions
What is the active ingredient in milk thistle?
Silymarin — a flavonolignan complex, main component silibinin. Not the seed/extract weight on the label. Standardized extracts are ~70–80% silymarin; compute active as extract mg × %. Content varies ~2,800% (Fenclová 2019: 35–125% of label).
What does the research say about milk thistle?
The research is modest and mixed. A 2024 meta-analysis pooled ALT/AST liver-enzyme markers in NAFLD trials (Li 2024); their clinical relevance is debated. No confirmed cirrhosis-mortality benefit (Rambaldi 2007 Cochrane null). The glucose data are low quality (Voroneanu 2016).
What amounts have been studied?
Research used ~200 mg silymarin 2–3×/day (~420 mg/day; range 140–800). Actual silymarin = extract mg × %. Most labels don't disclose the %, so you often can't compute the dose.
What are the side effects and cautions?
The most commonly reported side effect is mild GI upset. Cautions: ragweed-family (Asteraceae) allergy (NCCIH/MedlinePlus) and possible additive blood-sugar lowering with antidiabetic drugs. Little clinically significant CYP450 interaction at typical doses.
What has been studied about milk thistle and the liver?
A 2024 meta-analysis of 26 randomized trials in people with NAFLD reported lower ALT and AST with silymarin than with placebo. That is a lab-marker finding of debated clinical relevance. It does not show that milk thistle treats liver disease or improves survival.
Why do so many claimed milk thistle benefits have such uneven evidence?
Bioavailability is a big part of it. Plain silymarin is poorly and inconsistently absorbed orally — a human pharmacokinetic study found that complexing silybin with phosphatidylcholine produced much higher blood levels than the same silybin dose from plain silymarin, which is the whole rationale for phosphatidylcholine-complex products. On top of that, independent testing of commercial milk thistle supplements found large, inconsistent variation in actual silymarin content against the label. Between inconsistent absorption and inconsistent dosing, it's not surprising that positive results in tightly controlled trials don't always show up in weaker studies or real-world use.
What are the most common milk thistle side effects?
Mild gastrointestinal upset — loose stools, nausea, and bloating. A comprehensive review of the silymarin literature by Saller and colleagues, covering decades of trials, found milk thistle generally well tolerated, with GI disturbances the most frequently reported adverse effect and allergic skin rash reported only rarely. There's no confirmed dose-response pattern the way there is with, say, berberine's GI effects — most people who react do so early, and it isn't usually severe enough to stop taking it.
Can milk thistle trigger an allergic reaction?
Yes, and this is the caution worth taking seriously if it applies to you. Milk thistle (Silybum marianum) belongs to the Asteraceae family, along with ragweed, daisies, chrysanthemums, and marigolds, and cross-reactivity between family members is a recognized allergy pattern. A 2020 case report documented a man who developed respiratory symptoms after inhaling milk thistle and oral allergy symptoms after eating teff (a botanically related grain), confirmed by skin testing — a concrete example of the cross-reactivity, not just a theoretical family resemblance. If you have a known ragweed or Asteraceae allergy, talk to a doctor before starting milk thistle.
Does milk thistle interact with medications?
Less than early lab research implied, based on the human studies that followed it up. Milk thistle compounds inhibited several cytochrome P450 enzymes when tested against human liver microsomes in a dish. But when researchers tested actual milk thistle supplementation in healthy volunteers, using midazolam as a CYP3A4 marker, they found no clinically relevant effect on that enzyme's activity — a sharp contrast to the positive controls rifampin and clarithromycin, which changed midazolam clearance dramatically in the same study. A separate trial found milk thistle didn't meaningfully change digoxin levels (a P-glycoprotein marker), and a third found no effect on the prescription drug indinavir. The in-vitro warning didn't translate into a real-world effect in any of these human trials — but that's a pattern across several specific drugs tested, not a blanket clearance, so still tell your doctor or pharmacist what you're taking.
Who should be extra cautious with milk thistle?
People on diabetes medication and people with hormone-sensitive conditions. Silymarin may modestly lower fasting glucose, based on a meta-analysis of small trials rated low quality, so combining it with insulin or oral antidiabetic drugs could add to that effect — monitor your blood sugar if you're on one. Separately, an animal study found silymarin acts as a selective estrogen receptor beta agonist, with estrogen-like effects in bone but not in the uterus of ovariectomized rats. That's receptor-binding and animal data, not a human safety trial, but it's the basis for a standard caution against milk thistle in pregnancy, breastfeeding, and hormone-sensitive conditions like breast, uterine, or ovarian cancer, until it's better studied in people.
Related guides
- Berberine — another metabolic-support botanical with a standardization and dosing gap
- NAC — another antioxidant supplement
- Curcumin — another poorly-absorbed plant extract where the form and % on the label matter
Sources
- Rambaldi A, et al. "Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases." Cochrane Database Syst Rev. 2007. PMID: 17943794 (no confirmed mortality benefit).
- Li S, et al. "Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis." Ann Hepatol. 2024. PMID: 38579127 (26 RCTs; ALT/AST lower in the pooled trials).
- Voroneanu L, et al. "Silymarin in type 2 diabetes mellitus: a systematic review and meta-analysis of RCTs." J Diabetes Res. 2016. PMID: 27340676 (low-quality glucose signal).
- Fenclová M, et al. "Poor chemical and microbiological quality of commercial milk thistle supplements." Sci Rep. 2019. PMID: 31366891 (content 35–125% of declared).
- NIH LiverTox, "Milk Thistle (Silymarin)." NBK548817 (composition; ~70–80% silymarin standardization). NCCIH/MedlinePlus for the Asteraceae allergy caution.
- Full product dataset: /milk-thistle/cost-by-brand.json (CC BY 4.0).
- Fried MW, et al. "Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial." JAMA. 2012;308(3):274-82. PMID: 22797645
- Parés A, et al. "Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial." J Hepatol. 1998;28(4):615-21. PMID: 9566830
- Barzaghi N, et al. "Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects." Eur J Drug Metab Pharmacokinet. 1990;15(4):333-8. PMID: 2088770
- DiCenzo R, et al. "Coadministration of milk thistle and indinavir in healthy subjects." Pharmacotherapy. 2003;23(7):866-70. PMID: 12885100
- NCCIH, "Milk Thistle" (nccih.nih.gov) — ragweed/Asteraceae allergy caution. A consumer-health reference, not a clinical trial. (MedlinePlus retired its herb pages in 2026.)
- Zhong S, et al. "The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: a meta-analysis." Medicine (Baltimore). 2017. PMID: 29245314 (ALT −9.2 U/L, AST −6.6 U/L).
- Calderon Martinez E, et al. "Milk thistle (silymarin) and liver enzymes: a systematic review." Cureus. 2023. PMID: 38021897 (29 RCTs; enzymes fell in 65.5% of studies, no pooled effect size).
- Saller R, Meier R, Brignoli R. "The use of silymarin in the treatment of liver diseases." Drugs. 2001;61(14):2035-63. PMID: 11735632
- Wojas O, et al. "A case of allergy to Silybum marianum (milk thistle) and Eragrostis tef (teff)." Allergy Asthma Clin Immunol. 2020;16:23. PMID: 32322285
- Zuber R, et al. "Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities." Phytother Res. 2002;16(7):632-8. PMID: 12410543 (in-vitro, human liver microsomes)
- Gurley BJ, et al. "Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin." J Clin Pharmacol. 2006;46(2):201-13. PMID: 16432272
- Gurley BJ, et al. "Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans." Drug Metab Dispos. 2006;34(1):69-74. PMID: 16221754
- Seidlóvá-Wuttke D, et al. "Silymarin is a selective estrogen receptor beta (ERbeta) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats." J Steroid Biochem Mol Biol. 2003;86(2):179-88. PMID: 14568570 (animal/rat model)